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Renal effects of prostaglandin A1 in patients with essential
hypertension. To evaluate the effect of subvasodepressor doses
(0.! ig/kg/min) of prostaglandin A1 (PGA1) on renal function,
18 acute studies were performed on seven patients with essential
hypertension during both sodium loading and water diuresis.
During sodium loading, an increase in effective renal plasma flow
(ERPF), urine flow (V), urinary sodium excretion (UNaV), and
urinary potassium excretion was seen following PGA1 infusion.
The filtered sodium load remained stable while fractional sodium
excretion (hJNa/FNa) increased. Free water reabsorption (T20)
fell from baseline levels and approached negative values when
fractional sodium excretion was high. During water diuresis,
PGA1 infusion resulted in marked increases of ERPF, V, U,V,
and free water clearance (CH,O). The fraction of glomerular fil-
trate excreted (V/GFR) and the fraction of the filtered water load
excreted as free water (CH2O/GFR) increased sharply while the
fraction of glomerular filtrate reabsorbed in the proximal tubule
(GFR—V/GFR) fell. These results indicate that following sub-
vasodepressor doses of PGA1 in hypertensive patients, the
increased sodium excretion results primarily from decreased
proximal tubular sodium reabsorption with enhanced sodium
delivery to and transport by the distal tubule, especially in the
loop of Henle. These effects on renal function are probably the
result of hemodynamic and/or physical changes in the peritubular
capillaries following PGA1-induced vasodilatation.
Effets rénaux de Ia prostaglandine A1 chez des patients souffrant
d'hypertension essentielle. Dans le but d'évaluer l'effet de doses
non hypotensives (0.1 jig/kg/mm) de prostaglandine A1 (PGA1)
sur Ia fonction rénale, dix-huit ótudes aigUes ont été réalisées chez
sept patients atteints d'hypertension essentielle, au cours d'une
surcharge en sodium et d'une diurêse aqueuse. Durant Ia sur-
charge en sodium, des augmentations du flux plasmatique renal
efficace (ERPF), du debit urinaire (V), de l'excrétion urinaire du
sodium (UNaV), de l'excrétion urinaire du potassium ont été
observCes a Ia suite de perfusion de PGA1. La charge de sodium
filtré (FNa) est demeurée stable alors que Ia fraction excrétée du
sodium filtré (tJNa/FNa) a augmenté. La reabsorption de I'eau
libre (T0) a diminué comparativement au niveau de base
pour s'approcher de valeurs negatives quand Ia fraction
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excrétée du sodium filtré était é!evée. Au cours de Ia diurèse
aqueuse, Ia perfusion de PGA1 a produit des augmentations
importantes du ERPF, V. UNaV, et de Ia clearance de I'eau libre
(CH2O). La fraction excrétée du filtrat glomerulaire (V/GFR) et
Ia fraction de l'eau filtrée excrétée sous forme d'eau libre (CH2O/
GFR) a augmenté de facon abrupte alors que Ia fraction du
filtrat glomerulaire réabsorbé au niveau du tube proximal
(GFR—V/GFR) a diminué. Les résultats mndiquent qu'à Ia suite
de doses non hypotensives de PGA1 chez des patients hyper-
tendus, l'augmentation de l'excrétion du sodium résultate d'abord
d'une diminutation de Ia reabsorption tubulaire proximale du
sodium permettant ainsi qu'une plus grande quantité de sodium
soit présentée transportée par le tube distal, plus particuliêrement
I'anse de Henle. Ces effets sur Ia fonction rénale sont probable-
ment Ic résultat de medifications hémodynamiques et/ou physi-
ques qu'entraine, dans les capillaires pértubulaires, Ia vasodila-
tation produite par Ia PGA1.
The isolation of the prostaglandins, PGA2 and POE2,
from the renal medulla [1, 2] and the demonstration of
their potent antihypertensive properties [3] have led to
considerable interest and speculation as to the possible
role of the kidney as an antihypertensive organ [4, 51.
In this regard the effect of various prostaglandins on
renal function has been studied in normotensive dogs
(E1 and E2) [6, 7] and in normotensive and hypertensive
man (A1) [8, 9]. PGA1 administration produced no
change in blood pressure, urine volume (V), or electro-
lyte excretion in normotensive man (Patel, N.C., Per-
sonal Communication). In contrast, striking systemic
hemodynamic changes as well as changes in renal
function have been observed in patients with essential
hypertension [8—10].
In most reported studies in hypertensive man, PGA1
infusion has produced a prompt fall in arterial blood
pressure, a progressive rise in pulse rate and cardiac
output, and a decrease in peripheral resistance [8, 9j.
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These systemic effects appear to modify the effects of
PGA1 on renal function through a decrease in renal
arterial perfusion. Using moderate infusion rates (0.48
to 1.32 g/kg/min), Carr [8] found consistent increases
in V, glomerular filtration rate (GFR), rena'! plasma
flow (RPF), sodium excretion (UNaV), free water
clearance (CH2O), and potassium excretion (UKV) de-
spite a significant reduction in arterial blood pressure.
At higher infusion rates (2.1 to 11.2 tg/kg/min),
however, Lee [10] observed an even greater decrease
in blood pressure which was accompanied by reductions
in these previously elevated renal parameters to or
towards preinfusion levels.
The present study was designed to define more
precisely the effect of PGA1 on renal function in hyper-
tensive man when systemic effects were held to a mini-
mum. Changes in renal hemodynamics, in tubular
sodium transport, and in concentrating and diluting
capacity were investigated under conditions of sodium
loading and water diuresis before and after subvaso-
depressor PGA1 infusion. The results indicate a marked
increase in RPF, V, and UNaV following PGA1 inf u-
sion. In addition, evidence is presented for decreased
proximal tubular sodium reabsorption, resulting in
enhanced sodium delivery to and transport by the
distal tubule. This effect of PGA1 on tubular sodium
handling of the hypertensive kidney is in sharp contrast
to the effect of acute volume expansion alone [11], and
it provides new insight into the possible mechanism of
the exaggerated natriuresis in hypertensive man.
Methods
Eighteen acute studies were performed on seven
patients with essential hypertension in the Renal
Metabolic Laboratory and the Clinical Research Cen-
ter of the University of Tennessee. All patients were
black and ranged in age from 21 to 49. None of the
patients had significant cardiac or renal disease. The
diagnosis of essential hypertension was based on the
history, physical examination, and laboratory evalua-
tion which included complete blood count, urinalysis,
urine culture, serum electrolytes, blood urea nitrogen,
serum creatinine, 24-hour urine determination for vanil-
lylmandelic acid (V MA), rapid sequence intravenous
urogram, chest X-ray, and electrocardiogram. Anti-
hypertensive medications were discontinued two weeks
prior to hospitalization. All patients were on a regular
diet throughout the study period.
Each patient received a daily intravenous infusion of
the prostaglandin, PGA1, in 5% dextrose for one to
seven days prior to the study period. Following a steady
state period when the blood pressure, taken at one-
minute intervals, remained stable for at least five mm,
PGA1 was infused over a 6 to 12 mm period at a rate
of 0.1 jig/kg/mm. At this dosage, none of the patients
had a decrease in blood pressure. The infusion rate of
PGA1 was then increased by increments of 0.1 j.ig/kg/min
at ten-minute intervals until a significant drop in blood
pressure was obtained (fall of 30 mm Hg systolic or
15mm Hg diastolic blood pressure). The PGA1 infusion
rate producing a significant drop in blood pressure was
noted for each patient and it varied from 0.3 to 0.4
jig/kg/mm.
In the first series of experiments the effect of PGA1
infusion on renal function was studied during sodium
loading. All food and fluid were withheld for 12 hours
before each test and 0.5 U vasopressin was adminis-
tered i. m. 30 mm before experimental measurements
were begun. After appropriate priming doses of inulin
and p-aminohippurate (PAH), an i. v. infusion contain-
ing 10 % mannitol in 0.9 % saline was begun at a con-
stant rate of 10 ml/min with a Sigmamotor infusion
pump. This infusion delivered inulin at the rate of 30
to 40 mg/mm, PAH at 12 to 16 mg/mm and aqueous
vasopressin at 30 mU/kg/hr. Urine specimens were
collected from the bladder at approximately 10 mm
intervals through an indwelling catheter, and venous
blood samples were withdrawn from the forearm
through an indwelling needle at the midpoint of each
collection period. The infusion was continued until a
definite maximal TCH2o level (TcM1120) was established
at which time the infusion was replaced with a similar
infusion containing PGA1 in a dosage calculated to
delivery 0.1 jig/kg/mm. Six to eight additional 10 mm
periods were collected during PGA1 infusion, followed
by two to four periods after discontinuing the drug.
Blood pressure determinations were made at one-
minute intervals throughout these and all subsequent
studies.
In the second series of experiments the effect of PGA1
infusion on renal function was studied during water
diuresis. Patients were hydrated by oral ingestion of
1200 ml water at the beginning of the study. After each
urine collection, water was administered by mouth in
amounts equal to the urine volume passed during the
preceding period. An i.v. infusion of 0.9% saline
containing inulin and PAH as outlined above was
administered at a rate of 10 mI/mm. When urine flow
was stable for two to three consecutive periods, intra-
venous PGAI was administered at a rate of 0.1 pg/
kg/mm for six to eight consecutive periods.
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Inulin was measured in plasma and urine by the
method of Walser, Davidson, and Orloff [12]; PAH
was measured by a modification of the method of
Smith et a!. [13]. Serum and urinary sodium and potas-
sium were measured on an Instrumentations Labora-
tories flame photometer. Blood and urine osmolalities
were determined by the freezing point depression
method by use of an Advanced osmometer. Tcu2o was
calculated as C0m —V. Csm was calculated as UøsmV/
Osm, where Usm =osmolality of urine (mOsm/kg),
'Osm = osmolality of serum (mOsm/kg), and V =urine
flow (mi/mm). C1120 was calculated as VC0sm. The
clearance of inulin was utilized to represent glomerular
filtration rate (GFR); the clearance of PAH was
assumed to approximate effective renal plasma flow
(ERPF). ERBF was calculated from the formula,
ERBF= ERPF/1 — Hct. Standard statistical techniques
were used throughout [14].
Results
Renal hemodynamic studies. The effect of PGA1 on
renal hemodynamics was determined during sodium
loading and water diuresis (Fig. I, Table 1). During
PGA1 infusion, ERPF was sharply increased over the
control period both during sodium loading (33 %)and
water diuresis (43 %). Changes in ERBF paralleled
those of ERPF. The GFR remained relatively constant
throughout all expeliments with a resultant decrease in
filtration fraction (FF). The blood pressure showed no
troi[ [Ptinf ontrol PGA1 Postinf.
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Fig. 1. The effect of PGA1 on renal hemodynamics during sodium
loading and water diuresis. Each point represents a single clearance
period during the course of a typical experiment. Elapsed time is
from the beginning of the control collection.
significant change in any patient when the PGA1 in-
fusion rate was 0.1 pg/kg/mm.
Electrolyte excretion. Representative experiments
showing the effect of PGA1 on tubular sodium trans-
port during sodium loading and water diuresis are
shown in Figs. 2 and 3. The results of all experiments
are summarized in Tables 2 and 3. During sodium
Table 1. Effect of PGA1 infusion on renal hemodynamicsa
GFRb ERPFb ERBFb FF SBP DBP
Con- PGA1 Con- PGA Con- PGA1 Con- PGA1 Con- PGA1 Con- PGA1
trol trol trol trol trol trol
mI/mm mI/mm mI/mm % mmHg mml-Ig
Sodium 117 117 457 607 762 1066 26 20 166 157 106 100
Loading ±30 ±22 ±98 ±100 ±167 ±233 ±4 ±4 ±15 ±14 ±8 ±10
pc >0.90 <0.01 <0.01 <0.01 >0.05 >0.05
Water 124 130 490 701 754 1079 25 18 163 167 115 109
Diuresis +40 +36 +24 +28 +85 +123 +7 +5 +11 +13 +8 +11
pe >0.50 <0.01 <0.01 <0.05 >0.10 >0.50
Values are the means and standard deviations for eight experiments. Control observations are the means of 2 to 3 consecutive
collection periods; PGA1 observations are the means of 3 consecutive periods collected 20 to 50 mm after beginning infusion.
Abbreviations: SBP= systolic blood pressure; DBP= diastolic blood pressure; see text for others.
b Corrected to 1.73 m2 BSA.
c The P values were determined by the method of paired differences.
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Fig. 2. The effect of PGA1 on tubular sodium transport during sodium loading and water diuresis. Each point represents a single
clearance period during the course of a typical experiment. Elapsed time is from the beginning of the control collection.
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Fig. 3. Changes in CH2O and T20 resulting from PG,41 infusion during the course of a typical experiment. Each point represents a
single clearance period. Elapsed time is from the beginning of the control collection.
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Table 2. Summary of individual studies on
Patient
Vb T20b UNaYb
Control
mi/mm
PGA1 Control
rn//mm
PGAJ Control
pEq/min
PGA1
AS.
G.K.
L.M.D.
E.J.
M.A.B.
11.1
16.5
13.3
18.9
17.4
30.6
27.0
24.9
32.5
25.9
3.8
3.4
3.0
3.9
4.1
0.7
2.3
2.5
1.4
3.5
1,223
1,323
1,246
1,899
1,808
3,053
2,114
2,118
3,131
2,256
Mean
C
15.4
3.2
<0.01
28.2
3.2
3.6
0.4
<0.05
2.1
1.5
1,499
327
<0.05
2,534
513
a Control observations are the means of 2 to 3 consecutive collection periods before PGA1 infusion. PGA1 observations are the means
of 3 consecutive periods collected 20 to 50 mm after beginning infusion. Abbreviations See text.
Table 3. Summary of individual studies on
Yb CH2Ob UNaVb UNaV!FNaX 100
Control PGA1Patient Control PGA1 Control PGA1 Control PGA1
mi/mm mi/rn/n pEq/min %
A.S. 11.4 22.8 8.4 14.1 209 968 2.0 8.2
J.E.C. 15.9 32.3 11.4 19.7 263 1144 1.3 5.1
E.J. 23.3 34.8 17.5 21.1 642 1861 3.9 11.8
N.M. 13.3 24.5 9.4 15.8 272 899 1.5 5.1
Mean 16.0 28.6 11.7 17.7 347 1218 2.2 7.6
5.2 5.9 4.1 3.3 199 441 1.2 3.2
pc <0.05 <0.01 <0.01 <0.05
Control observations are the means of 2 to 3 consecutive collection periods before PGA1 infusion. PGA1 observations are the means
of 3 consecutive periods collected 20 to 50mm after beginning infusion. Abbreviations: CH2O=free water clearance; V/GFR=
fraction of glomerular filtrate excreted; CH2O/GFR = fractionof the filtered sodium reabsorbed in the distal tubule; GFR — V/GFR=
fraction of glomerular filtrate reabsorbed in the proximal tubule.
loading, Y increased from 15.4 ml/min in the control
period to 28.2 ml/min with the intravenous infusion of
PGA1 (Table 2). The rise in V was associated with a
rise in UNaV from 1,499 to 2,534 j.tEq/min while the
filtered sodium load (FNa) showed no significant
change. The fraction of the filtered sodium load ex-
creted (UNaY/FNa) rose consistently from a control
mean of 10.1 % to a mean of 17.1 % while the fraction
of the filtered sodium load reabsorbed (TNa/FNa) fell
in corresponding fashion. Tc2o decreased from a mean
value of 3.6 to 2.1 ml/min, but individual periods of
some experiments resulted in the formation of negative
TCH2O during PGA infusion when fractional sodium
excretion was high. UKV increased in every experiment
following PGA1 administration and was comparable
to the increase in UNaV during corresponding periods
(Fig. 4).
During water diuresis, Y, UNaV, and CH2o rose
progressively to stable mean control values of 16 mI/mm,
347 jiEq/min, and 11.7 mI/mm, respectively (Table 3).
With infusion of PGA1, V increased sharply to
28.6 ml/min. The rise in V was associated with a marked
increase in UNaV to 1,218 j.tEq/min and CH20 to
17.7 mi/mm while FNa showed no significant change.
In addition, PGA1 administration resulted in a prompt
rise in UNaV/FNa with a corresponding decrease in
Renal effects of PGA1 in hypertension
tubular sodium transport during sodium loadinga
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UKVb FNab UNaV/FNaX 100 TNa/FNaX 100
Control PGA1Control PGA1Control PGA1 Control PGA
pEq/min pEq/min % %
173 235 16,141 15,383 7.6 19.8 92.4 80.2
124 185 15,169 12,674 8.7 16.7 91.3 83.3
189 291 8,946 11,807 13.9 17.9 86.1 82.1
171 252 19.898 19,703 9.5 15.9 90.5 84.1
119 178 16,666 14,677 10.8 15.4 89.2 84.6
155 228 15,364 14,847 10.1 17.1 89.9 82.9
32 47 4,003 2,679 2.4 1.8 2.4 1.8
<0.01 >0.50 <0.01 <0.01
13 Corrected to 1.73 m2 BSA.
C The P values were determined by the method of paired differences.
tubular sodium transport during water diuresisa
TNaIFNaX 100 V/GFRx 100 C20/GFRx 100 GFR—V/GFRx 100
Control PGA1 Control PGA1 Control PGA1 Control PGA1
% % % %
98.0 91.8 14.7 25.7 10.9 14.9 85.3 74.3
98.7 94.9 10.6 19.5 7.6 11.9 89.4 80.8
96.1 88.2 19.9 32.9 15.0 20.0 80.0 67.2
98.5 94.9 9.2 18.1 6.6 11.7 90.8 81.9
97.8 92.5 13.6 24.1 10.0 14.6 86.4 76.1
1.2 3.2 4.8 6.8 3.8 3.9 4.9 4.6
<0.05 <0.01 <0.001 <0.001
b Corrected to 1.73 m2 BSA.
The P values were determined by the method of paired differences.
TNa/FNC. The fraction of glomerular filtrate excreted
into the urine (V/GFR) increased from a control of
13.6% to 24.1 %. Similarly, the fraction of the filtered
water load excreted as free water (CH2O/GFR) increased
from a mean of 10.0% to 14.6% while the fraction of
glomerular filtrate reabsorbed in the proximal tubule
(GFR—V/GFR) decreased 86.4 to 76.1 %.
Discussion
The present results agree most closely with those in
which systemic hemodynamic changes were avoided
by infusing prostaglandin directly into the renal artery
of normotensive dogs. Significant increases in V, UNaV,
RPF [6, 7] and C20 [6] were observed on the infused
side while GFR [6, 7] and mean aortic pressure [6]
remained unchanged. The effect of vasodepressor doses
of PGAI on renal function appears to be modulated by
the systemic hemodynamic changes of a reduction in
arterial blood pressure, increase in cardiac output, and
decrease in peripheral vascular resistance as manifested
by the resultant decrease in renal arterial perfusion.
Our findings resemble more closely those of Carr [8]
where lower infusion rates produced a lesser reduction
in systemic arterial pressure, as opposed to those of
Lee [10] where higher infusion rates were employed.
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Fig. 4. Changes in potassium excretion as related to sodium ex-
cretion before (closed symbols) and during (open symbols) the
administration of PGA1 in five patients with essential hypertension.
Each point represents a single clearance period and each patient
is designated by a different symbol.
Most of the changes that we observed, including the
increase in ERPF, V, UNaV, and CH20, could be attrib-
uted to some function of renal vasodilatation and were
similar in nature to the changes caused by other renal
vasodilators [15—17]. Renal vasodilatation has been
shown to enhance UNaV by decreasing TNa [15, 18];
increased sodium excretion in the present studies also
appeared to be related to decreased TN, since FNa
remained unchanged while UNa/FNa increased in every
instance.
The exaggerated natriuresis that occurs in hyperten-
sive man following acute volume expansion with saline
[11, 19, 20] has been attributed largely to a reduction in
sodium reabsorption in the loop of Henle [11]. Both
TCH20 and CH20 formation were found to be abnor-
mally low when compared to normal subjects under the
same experimental conditions [11]. In contrast, during
PGA1 infusion in the present studies, maximal TCHZO
formation was reduced in all experiments while CH20
formation increased consistently despite the continued
presence of hypertension. These observations suggest
that the exaggerated natriuresis of volume expansion
in hypertensive patients and that observed during PGA1
infusion may be derived from differing nephron seg-
ments. In addition, they also suggest that PGA1 im-
proves the defect in loop sodium reabsorption, at least
within the diluting segment, as manifested by the
increase in CH2O formation.
Under conditions of maximal water diuresis, CH20 is
formed within the ascending limb of the loop of Henle
and distal tubule. In this context C1120 reflects distal
sodium transport and CH2O/GFR is an indirect index of
fractional sodium reabsorption in the distal tubule.
Since the relative impermeability of the distal nephron
to water during water diuresis minimizes additional
watei absorption, V may be employed as an estimate
of distal sodium delivery and V/GFR as an indirect
index of the fractional sodium load reaching the
ascending limb. Similarly, the percentage of glomerular
filtrate ieabsorbed in the proximal tubule may be
approximated by the expression GFR —V/GFR. Table 3
discloses that PGA1 increased both delivery (V) and
fractional delivery (V/GFR) of sodium from the pioxi-
3,000 3,500 mal tubule to the ascending limb while decreasing the
fraction of filtrate reabsorbed in the proximal tubule
(GFR—V/GFR). In addition both distal sodium reab-
sorption (C1120) and fractional reabsorption (CH2O/
GFR) were increased. Additional evidence for increased
distal reabsorption was obtained during sodium load-
ing as the rise of sodium excretion was paralleled by a
corresponding increase of potassium excretion (Fig. 4).
While the observed increase in distal sodium reabsorp-
tion might have been even greater under comparable
conditions of increased delivery in healthy normoten-
sive man, the observed formation of C1120 suggests that
such differences are probably negligible.
The divergent effects of PGA1 on T112O and C1120
formation might be related to the inhibition of sodium
reabsorption in the deeper portions of the ascending
limb of Henle's loop, but not in the diluting segment.
Nevertheless, factors other than altered sodium reab-
sorption by the medullary ascending limb per se may
influence T20 formation, including the rate of
medullary blood flow, the collecting duct permeability
to water, and the ability of distal tubular fluid to
achieve isotonicity [21]. Changes in medullary blood
flow may have a profound influence on urinary con-
centration. Increased medullary blood flow may result
in decreased concentrating ability, presumably by
reducing the medullary solute concentration. Decreased
medullary blood flow may limit water removal from
the medullary interstitium in the face of increased
water reabsorption from the descending limb of Henle's
loop and the collecting ducts. Intrarenal prostaglandin
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infusion in normotensive dogs produces an increase in
cortical blood flow; its effect on medullary flow causes
either a decrease [22] or no change [23]. If a similar
effect on medullary flow occurs in hypertensive man,
medullary solute concentration could be sufficiently
compromised to blunt TCH2o formation. A decrease in
the collecting duct permeability to water also cannot
be excluded completely from lowering TCH20, since
Orloff et al. [24] have reported that PGE1 inhibits the
vasopressin-induced transport of water across the toad
bladder. However, Johnson et al. [6] observed a pro-
portional decrease in CH2O formation by both kidneys
of water-loaded dogs in response to vasopressin inf u-
sion despite the simultaneous infusion of PGEI into the
left renal artery. The decline in Tc1120 formation fol-
lowing PGA1 infusion may well be related to a de-
creased ability of distal tubular fluid to achieve iso-
tonicity. The rapid action of PGA1 on renal function
(Figs. 1 and 3) with a sudden increase in V, UNaV,
ascending limb sodium delivery and distal reabsorption
suggests that the large quantities of freed distal water
may exceed the capacity of the collecting duct to return
the hypotonic distal fluid to isotonicity.
The exaggerated natriuresis of salt-loading in hyper-
tensive man was ascribed by Buckalew [II] to an
abnormal renal response to extracellular fluid expan-
sion, primarily due to a defect in loop sodium transport
although evidence for proximal rejection was also
present. This defect in Henle's loop was attributed to
increased renal perfusion pressure in the medullary
vasa recta during saline loading rather than to an
intrinsic defect in loop sodium reabsorption [11]. While
acute volume expansion in the present studies may
have produced a similar effect during the control period,
the results indicate that following PGA1 infusion, a
sharp additional increase in sodium excretion occurred,
which declined in the post PGAI period despite con-
tinued fluid administration at the same infusion rate.
In addition, the natriuresis produced was derived
primarily from increased proximal rejection with en-
hanced distal delivery and reabsorption, especially in
the loop of Henle.
The mechanism whereby proximal tubular sodium
reabsorption is diminished in hypertensive patients by
PGA1 is unknown, but it may be related to the hemo-
dynamic and/or physical changes that occur in pen-
tubular capillaries following renal vasodilatation
[25, 26]. The marked increase in cortical blood flow
and intrarenal perfusion pressure (or a corresponding
decrease in colloid oncotic pressure in peritubular
capillaries) may 1ead to an imbalance of Starling forces
across the capillary wall which can alter proximal
sodium reabsorption. Whether alterations in similar
factors or some more direct effect of PGA1 on renal
tubular epithelium are responsible, the characteristic
defect in ioop sodium transport in the hypertensive
state [11,27] would appear to be improved without
antihypertensive action at least within the cortical
diluting segment.
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